Both in Biotechnology
Calidi Biotherapeutics vs PharmaCyte Biotech
Over the past year CLDI returned −97.1% and PMCB returned −66.0%; their daily moves had a correlation of -0.04.
CLDI −97.1% PMCB −66.0%Growth of $1, one year, split-adjusted
| Metric | CLDI | PMCB |
|---|---|---|
| Price | $0.7018 | $0.3347 |
| Market cap | $1.8M | $3.6M |
| Today | +6.33% | −2.45% |
| 1 month | −35.0% | −20.1% |
| 6 months | −79.0% | −55.4% |
| Year to date | −96.3% | −53.8% |
| 1 year | — | −66.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $3.1M | $30.5M |
| Dividend yield | — | — |
| Volatility (60d) | 79.5% | 61.5% |
| Short % of float | 0.9% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).